Details for New Drug Application (NDA): 040028
✉ Email this page to a colleague
The generic ingredient in KIONEX is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for 040028
Tradename: | KIONEX |
Applicant: | Ani Pharms |
Ingredient: | sodium polystyrene sulfonate |
Patents: | 0 |
Suppliers and Packaging for NDA: 040028
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
KIONEX | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 040028 | ANDA | ANI Pharmaceuticals, Inc. | 62559-356 | 62559-356-01 | 10 BOTTLE in 1 CASE (62559-356-01) / 60 mL in 1 BOTTLE (62559-356-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL, RECTAL | Strength | 15GM/60ML | ||||
Approval Date: | Sep 17, 2007 | TE: | AA | RLD: | No |
Complete Access Available with Subscription